Universal Beteiligungs Und Servicegesellschaft Mb H Ironwood Pharmaceuticals Inc Call Options Transaction History

Universal Beteiligungs Und Servicegesellschaft Mb H

  • $48.1 Billion
  • Q4 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $248M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Universal Beteiligungs Und Servicegesellschaft Mb H Portfolio

Follow Universal Beteiligungs Und Servicegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Universal Beteiligungs Und Servicegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Universal Beteiligungs Und Servicegesellschaft Mb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email